Chinese Pharmaceutical Market Forecast 2017-2027

LONDON, September 28, 2017 /PRNewswire/ --

Cardiovascular Diseases, Oncology, Respiratory Diseases, Infectious Diseases, Diabetes, CNS, Autoimmune Diseases, Hypertension, Dyslipidaemia, COPD, Asthma, Antidepressants, Small Molecules, Branded Drugs, Traditional Chinese Medicine, Biologics, Vaccines, Biosimilars, Generic Prescription Drugs, Over-the-Counter Drugs, Patented Prescription Drugs, Hospitals, Retail Pharmacies, Grassroots Clinics

The Chinese Pharmaceutical market is expected to grow at a CAGR of 12.3% in the second half of the forecast period. The Chinese Pharmaceutical market reached $145.4bn in 2016, dominated by the Cardiovascular therapy area which held 13.6% share of the market.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 253-page report you will receive 68 tables and 90 figures- all unavailable elsewhere.

The 253-page report provides clear detailed insight into the Chinese Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

• Chinese Pharmaceutical market forecasts  from 2017-2027

• This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by therapy area:
- Cardiovascular: including specific revenue forecasts for Hypertension and Dyslipidaemia
- Anticancer
- Infectious Diseases
- Diabetes
- Respiratory: including specific revenue forecasts for Asthma and COPD
- Central Nervous System: including specific revenue forecasts for Antidepressants
- Autoimmune
- Others

This report lists and discusses the domestic pharmaceutical companies that dominate each submarket. Moreover, this report discusses the drivers and restraints of each submarket.

• This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by leading product class:
- Small Molecules: further broken down into Generics Drugs and Branded Drugs
- Traditional Chinese Medicine
- Biologics: further broken down into Biologics (branded), Vaccines and Biosimilars

This report lists and discusses the domestic pharmaceutical companies that dominate each submarket. Moreover, this report discusses the drivers and restraints of each submarket.

• This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by leading type of drug:
- Generic Prescription Drugs
- Over-the-Counter (OTC) Drugs
- Patented Prescription Drugs

This report lists and discusses the domestic pharmaceutical companies that dominate each submarket.

• This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by sales channel:
- Hospitals
- Retail Pharmacies
- Grassroots Clinics

This report lists and discusses the domestic pharmaceutical companies that dominate each submarket.

• This report discusses trends in the industry and assesses strengths and weaknesses, as well as opportunities and threats (SWOT) that influence the Chinese Pharmaceutical Market. It also analyses social, technological, economic and political factors (STEP) that influence the Chinese Pharmaceutical Market

• Our study ranks and provides 2016 revenues as well as market share of the top 50 domestic Chinese Pharmaceutical companies and top 10 Multinational Pharmaceutical Companies that are the major players in the Chinese Pharmaceutical Market

• Our study lists and discusses the leading domestic and multinational Contract Research Organizations (CRO) that dominate the Chinese Pharmaceutical Market.

Visiongain's study is intended for anyone requiring commercial analyses for the Chinese Pharmaceutical market. You find data, trends and predictions.

Buy our report today Chinese Pharmaceutical Market Forecast 2017-2027: Cardiovascular Diseases, Oncology, Respiratory Diseases, Infectious Diseases, Diabetes, CNS, Autoimmune Diseases, Hypertension, Dyslipidaemia, COPD, Asthma, Antidepressants, Small Molecules, Branded Drugs, Traditional Chinese Medicine, Biologics, Vaccines, Biosimilars, Generic Prescription Drugs, Over-the-Counter (OTC) Drugs, Patented Prescription Drugs, Hospitals, Retail Pharmacies, Grassroots Clinics, Domestic Pharmaceutical Companies, Multinational Pharmaceutical Companies.

To request a report overview of this report please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100.

Or click on https://www.visiongain.com/Report/1998/Chinese-Pharmaceutical-Market-Forecast-2017-2027

List of Companies Mentioned in the Report 

3SBio

Acambis

Agilent

Alibaba Group

Alliance Boots

Amerisource-Bergen

Amgen

Anhui Anke Biotech

AppTech Laboratory Services

Asian Cancer Research Group

Astellas

AstraZeneca

Asymchem Laboratories

AXM Pharma

Baxter

Bayer

Bayer Healthcare

BeiGene

Beijing Four Rings Bio-pharmaceutical

Beijing Genomics Institute

Beijing Kexing Bioproducts

Beijing Key Yuan Xinhai Pharmaceutical

Beijing SL Pharmaceutical

Beijing Taiyang

Beijing Tiantan Biological Products

Beijing Tong Ren Tang

Bio-Bridge Science

BiODura

Bloomberg

Boehringer Ingelheim

Bristol-Myers Squibb

Buchang Pharma

Cardinal Health

CASiGEN Pharma

Celgene

Celsion Corp

Changzhou Qianhong Biopharma

Chemizon (Beijing) Pharma-Tech

Chengdu Di'ao Pharmaceutical Group

Chengdu Institutes of Biological Products

Chiesi Edding Hong Kong Limited

Chi-Med

China Chemical & Pharmaceutical Group

China National Accord

China National Biotec Group

China National Pharmaceutical Group

China NT Pharma Group

China Pharmaceutical Commerce Association

China Pharmaceutical Quality Management Association

China Resources Double-Crane Pharmaceuticals

China Resources Sanjiu Medical

China Shineway Pharmaceutical

China Traditional Chinese Medicine Co.

ChinaBio Group

ChinaGate

Chonqqing Taiji Industry

Cipla

Consun Pharmaceutical Group

Cord Blood America

Covance

CSPC Pharmaceutical Group

Daan Gene

Daiichi Sankyo

Dalian Hissen Bio-Pharm

Dawnrays Pharmaceutical Holdings

Dihon Pharmaceutical Group

Dongsheng Pharmaceutical

Dr. Reddy's Laboratories

Egret

Eisai

Eli Lilly

Excel PharmaStudies

FeRx Incorporated

Financial Times

Foshan City

Furen Pharmaceutical Group

Gan & Lee Pharmaceutical

Genentech

GeneScience Pharmaceuticals

Gilead Sciences

GlaxoSmithKline

Goldman Sachs

Guangdong BeiKang Pharmaceutical

Guangdong Techpool

Guangxi Wuzhou Zhongheng Group

Guangzhou Medical University

Guangzhou Pharma

Guangzhou Pharmaceutical Corporation

Guizhou Baiqiang Pharmaceutical

Hangzhou East China Pharmaceutical Group

Hangzhou Jiuyuan Gene Engineering

Hangzhou Tigermed Consulting

Hangzhou Zhongmei Huadong Pharmaceutical

Harbin Pharmaceutical Group

Harbin Tri-Lion Pharmaceutical

Harvard University

HD Biosciences

Henan Lingrui Pharmaceutical

Hengrui

Henlius Biopharmaceuticals

HitGen

Hua Medicine

Huadong Medicine

Hualan Biological Engineering

Hualida Biotech

Hutchinson Whampoa

Hutchison MediPharma

i3 Research

ICON

Inner Mongolia Yili Energy

Innovent Biologics

JD.com (Jindong Mall)

JHL Biotech

Jiangsu Chia-tai Tianqing Pharmaceutical

Jiangsu Hansen Pharmaceutical

Jiangsu Hansoh Pharmaceutical

Jiangsu Hengrui Medicine

Jiangsu Nhwa Pharmaceutical

Jilin Extrawell Changbaishan

Jilin Province Huinan Changlong

Jinling Pharmaceutical

Johnson & Johnson

Joincare Pharma

JOINN Laboratories

Kangmei Pharmaceutical

KPC Pharmaceuticals

Lepu Medical

Livzon Pharmaceutical Group

Lundbeck

Lundbeck Institute

Massachusetts Institute of Technology

McKesson

Merck & Co.

Merck Sharp & Dohme

Microport Medical

Mycenax

Mylan

Nanjing Kanghai Pharmaceutical

Nanjing Pharmaceutical Factory

Nestle Health Sciences

Nestle SA

Newsummit Biopharma

North China Pharmaceutical Group

Northeast Pharmaceutical Group (NEPG)

Novartis

Novast Laboratories

Novo Nordisk

Oncobiologics

Otsuka

Pfizer

Pharmaceutical Product Development LLC

Pharmaron

PKU Healthcare Group

Qilu Pharmaceutical

Quintiles

Roche

Sanofi

Schering-Plough

Servier

Shandong Dong-E E-Jiao

Shandong Kexing Bioproducts

Shanghai Celgen Bio-Pharmaceutical

Shanghai Charity Foundation

Shanghai CP Guojian Pharmaceuticals

Shanghai DND Pharm-Technology

Shanghai Fosun Pharmaceutical Group

Shanghai Furen Industrial

Shanghai Institutes of Biological Sciences

Shanghai Jinhe Bio-Technology

Shanghai Pharmaceuticals Holding

ShangPharma

Shenzhen Heapalink

Shenzhen Kangtai Biological Products

Shenzhen Neptunus Bioengineering

Shenzhen Salubris Pharmaceuticals

Shenzhen Wenle ('Main Luck') Pharmaceutical

Shijiazhuang Pharmaceutical Group

Shijiazhuang Yiling

Shineway Pharmaceutical Group

Sichuan Jiufeng Pharmaceutical

Sichuan Kelun Pharmaceutical

Sichuan Kelun Pharmaceutical

Sichuan Yuanda Shuyang Pharmaceutical

Sihuan Pharmaceutical Holdings

Simcere Pharmaceutical

SiniWest Holdings

Sino Biological

Sino Biopharmaceutical

Sinopharm

State Key Lab of Respiratory Disease

Sundia MediTech

Sundiro Pharma

Swiss Re

Symbio Pharmaceuticals

Takeda

Tangshan Yian Bioengineering

Tasly Pharmaceuticals

Teva

The Financial Times

Thermo Fisher Scientific

Tianjin Jin Yao Group

Tianjin Kinnovata Pharmaceutical Company

Tonghua Dongbao

United Pharmatech

Vectura

Venturepharm Laboratories

Vertex Pharmaceuticals

Viva Biotech

Wai Yuen Tong Medicine Holdings

Walmart Holdings

Wanbang Biopharmaceuticals

Weigao Holding

Winteam Pharmaceutical Group

WuXi AppTec

Xiamen Amoytop Biotech

Xian-Janssen Pharmaceuticals

Xiuzheng Pharmaceutical

Xizang Haisco

Yabao Pharmaceutical Group

Yangtze River Pharmaceuticals

Youcare Pharmaceutical Group

Yunnan Baiyao

Zai Lab

Zendex Bio Strategy

Zensun (Shanghai) Sci & Tech

Zhejiang Beta Pharma

Zhejiang Hisun Pharmaceutical

Zhejiang Huahai Pharmaceutical

Zhejiang Medicine

Zhejiang Tianyuan

Zhenjian Hisun Pharmaceuticals

Zhuhai United States Labs

Zuellig Pharma China

To see a report overview please email Sara Peerun on [email protected]

SOURCE Visiongain Ltd